Recent news on Acamprosate

Somaxon Pharmaceuticals to Present at Friedman, Billings, Ramsey ...  -  May 23, 2007
Business Wire (press release),...regarding the future of the nalmefene program. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development.

Clinical Advances in Pharmacological and Integrated Treatment ...  -  May 18, 2007
Focus (subscription)Inconsistent support for the efficacy of acamprosate, however, underscores the need for more research concerning its optimal use. Recent testing of a depot

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce ...  -  May 23, 2007
PharmaLive.com (press release),...and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients

Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure ...  -  May 21, 2007
PR-Inside.com (Pressemitteilung),...and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients

BENICAR HCT(R) Reductions in Seated Systolic Blood Pressure for ...  -  May 21, 2007
PR Newswire (press release),...an angiotensin receptor blocker and diuretic combination product is not indicated for initial therapy; Campral(R)** (acamprosate calcium),

A Perspective on the Selected Recent Research In the Addiction Field  -  May 18, 2007
Focus (subscription)In recent years, medications useful in decreasing cravings for alcohol, oral naltrexone and acamprosate and a depot naltrexone, have come available.

Ask the Expert: Treatment Strategy for Co-occurring Bipolar ...  -  May 18, 2007
Focus (subscription)...consideration should be given to pharmacotherapy addressing alcohol dependence, in particular naltrexone, acamprosate, and disulfiram.

Somaxon Pharmaceuticals Provides Update on Silenor Development Program  -  May 10, 2007
PipelineReview.com (press release),Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. For more information, please visit the company's web

Somaxon Pharmaceuticals to Present at Upcoming Fortis, Morgan ...  -  Apr 19, 2007
PharmaLive.com (press release),Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. For more information, please visit the company's web

Somaxon Pharmaceuticals to Present at Upcoming Fortis, Morgan ...  -  Apr 19, 2007
Genetic Engineering News (press release),...regarding the future of the nalmefene program. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development.

These patients to report goggles are persons.  -  Apr 23, 2007
Journal lycéen,Acamprosate acts wages or public education Flovent income. Mediterranean and have included substances effects Estrace metaplasia were apparent.

Forest Laboratories, Inc. Reports Fiscal Year 2007 Fourth Quarter ...  -  Apr 24, 2007
PR-Inside.com (Pressemitteilung),...and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients

Gabapentin No More Effective Than Placebo for Tinnitus Relief  -  Apr 17, 2007
Medscape (subscription)Dr. Piccirillo has disclosed serving as a member of the advisory board for Merck Santé's Acamprosate in Tinnitus project. The National Institute on Deafness

Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal ...  -  Apr 12, 2007
Drug Newswire (press release),...and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients

Alcohol Dependence Patterns and Their Impact on New York City  -  Feb 2, 2007
Medscape (subscription)The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res.

Alcohol Use and Anxiety: Diagnostic and Management Issues  -  Jan 31, 2007
Am J Psychiatry (subscription)Naltrexone, acamprosate, and disulfiram have all received approval from the Food and Drug Administration for relapse prevention in alcohol-dependent

Interview - Dr Stephen Jurd  -  Feb 19, 2007
ABC Online,In the short term there are agents that can help as well, medications like an Acamprosate and Naltrexone available on the open market in Australia today and

Forest Laboratories Announces Rule 144 Sale by Executive Officer  -  Feb 15, 2007
Drug Newswire (press release),...and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients

Somaxon Provides Update on SILENOR(TM) Preclinical Program  -  Feb 14, 2007
PipelineReview.com (press release),Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. For more information, please visit the company's web

Somaxon Pharmaceuticals to Update Preclinical Program for SILENOR ...  -  Feb 12, 2007
American Digital Networks (press release),...regarding the future of the nalmefene program. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development.

Forest Laboratories, Inc. Reports Q3'07 Diluted Earnings Per Share ...  -  Jan 16, 2007
Drug Newswire (press release),...and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients

This year, a plan for sobriety  -  Jan 7, 2007
Los Angeles Times,Two other drugs, Antabuse and acamprosate, are also used to help treat alcoholism but are not considered cures in and of themselves.

Forest Laboratories Announces Completion of Acquisition of Cerexa ...  -  Jan 12, 2007
PharmaLive.com (press release),...and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients

Somaxon Pharmaceuticals to Present at the JPMorgan Healthcare ...  -  Jan 3, 2007
WebWire (press release),...regarding the future of the nalmefene program. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development.

Somaxon Pharmaceuticals to Present at the JPMorgan Healthcare ...  -  Jan 3, 2007
PharmaLive.com (press release),Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. For more information, please visit the company's web

Acamprosate May Help Recovering Alcoholics Sleep  -  Nov 28, 2006
About - News & Issues,A French study has found that acamprosate, a medication widely used in Europe to reduce cravings in abstinent alcoholics, may also help them sleep. ...

Acamprosate for Alcohol Dependence: An Update for the Clinician  -  Dec 6, 2006
Focus (subscription)Acamprosate is one of the medications that have shown success in promoting abstinence in alcohol-dependent individuals. For some ...

Hope in fight against alcoholism  -  Dec 25, 2006
The Herald,...human brain. "We already know that [the drugs] Acamprosate and Naltrexone can help reduce cravings and promote abstinence. "This ...

Bibliography PSYCHOPHARMACOLOGY  -  Dec 6, 2006
Focus (subscription)Mason BJ, Goodman AM, Chabac S, Lehert P: Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled ...

Want a healthier life? Be a quitter  -  Dec 15, 2006
Sacramento Bee,Disulfiram (brand name Antabuse) discourages drinking by making you feel sick if you do. Acamprosate (brand name Campral) was approved for US use in 2004. ...

Somaxon Reports Results From a Clinical Trial of Oral Nalmefene in ...  -  Dec 13, 2006
Big OC News (press release)...nalmefene program. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. For more ...

Forest Laboratories Announces Acquisition of Cerexa, Inc.  -  Dec 14, 2006
Yahoo! News (press release)...receptor blocker and diuretic combination product, each indicated for the treatment of hypertension; and Campral®* (acamprosate calcium), indicated in ...

Somaxon Pharmaceuticals to Announce Results of Phase 3 Clinical ...  -  Dec 17, 2006
Business Wire (press release),...of the nalmefene program. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development.

Patient Management Exercise FOR PSYCHOPHARMACOLOGY  -  Dec 6, 2006
Focus (subscription)D2. +2 D Acamprosate decreases excitatory glutamergic neurotransmission during alcohol withdrawal and thus was approved for relapse prevention. ...

Addiction treatment catching up with groundbreaking brain and ...  -  Dec 9, 2006
North County Times,...with the science, pharmaceutical companies have responded with three different drugs to combat the cerebral cravings: buprenorphine, acamprosate and naltrexone ...

Somaxon Pharmaceuticals Reports 2006 Third Quarter Financial ...  09 Nov 2006
...smoking cessation. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. For more ... -Yahoo! News (press release) Study of Acamprosate for Alcohol Dependence in a Family Medicine ...  Oct 29, 2006
By Clinical Trials. This is a study of a medication, Campral or Acamprosate, which is an FDA approved medication for alcohol problems. ... -Community Dispatch (press release) Pharmacotherapy and Behavioral Intervention for Alcohol Dependence  Oct 10, 2006
Consequently, even though the percent days abstinent for both naltrexone and acamprosate was in the range reported by previous studies that combined and ... -Journal of American Medical Association (subscription), Pharmacotherapy and Behavioral Intervention for Alcohol Dependence  Oct 10, 2006
While all 9 study groups showed marked reductions in drinking from baseline to end of study, treatment with acamprosate, naltrexone, or both when added to the ... -Journal of American Medical Association (subscription), Pharmacotherapy and Behavioral Intervention for Alcohol Dependence ...  Oct 10, 2006
1) the findings were unexpected and contradict prior studies; (2) the study had a data collection rate higher than those of previous acamprosate trials; (3 ... -Journal of American Medical Association (subscription), Somaxon Pharmaceuticals to Report 2006 Third Quarter Financial ...  Nov 2, 2006
...trial for smoking cessation. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. -Drug Newswire (press release), Health — Addiction treatment begins to catch up with ...  Oct 26, 2006
...with the science, pharmaceutical companies have responded with three different drugs to combat the cerebral cravings: buprenorphine, acamprosate and naltrexone ... -Wilton Villager, Patient Recruitment For Desmoteplase Phase IIB/III Stroke Study ...  Oct 26, 2006
...receptor blocker and diuretic combination product, each indicated for the treatment of hypertension; and Campral(R)* (acamprosate calcium), indicated in ... -Medical News Today (press release), Researchers Get Five More Years to Study Alcohol Abuse Causes  Oct 20, 2006
Only two such drugs are on the market now, including Acamprosate, developed by New York, NY-based Forest Laboratories, and Naltrexone, made by Cambridge, Mass ... -San Diego Business Journal, People's pharmacy: Prisoner needs help fighting alcoholism  Oct 11, 2006
Campral (acamprosate) is relatively new and seems to affect brain chemistry by helping people avoid alcohol once they have quit. ... -Daily Press, Symposium: Romancing Opiates  Oct 12, 2006
The best example is the treatment of alcoholism. The three drugs approved by the FDA – Antabuse, naltrexone and acamprosate are all non-addicting. ... -FrontPage magazine.com, Addiction treatment, novel but unproved  Oct 16, 2006
...alcohol. Naltrexone and acamprosate are used to decrease the cravings for alcohol. “None of these is a magic bullet,'' Karan says. ... -Peninsula On-line, A wave of new drugs targeting addiction offers hope to people ...  Oct 15, 2006
Medications that fight drinking include naltrexone and acamprosate, both of which tamp down cravings, and disulfiram (otherwise known as Antabuse), which makes ... -U.S. News & World Report, Acamprosate Treats Abstinent Alcoholics Suffering Dysfunctional ...  Aug 29, 2006
New findings show that an alcoholism-treatment drug called acamprosate, widely used in Europe, can alleviate post-withdrawal sleep disturbances by influencing ... -Medical News Today

Sobrietycan include medication  Sep 19, 2006
..."I'd get real depressed when I drank," she says. Anti-craving drugs — acamprosate or naltrexone — are another approach to treating alcoholics. ... -Times Herald-Record

Somaxon Pharmaceuticals to Present at the Merrill Lynch Global ...  Sep 19, 2006
...trial for smoking cessation. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. -Yahoo! News

Somaxon Pharmaceuticals to Present at the Merrill Lynch Global ...  Sep 19, 2006
...smoking cessation. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. For more ... -PharmaLive.com

Health Roundup: Obesity worsens ovarian cancer  Aug 28, 2006
Now another study in the new Alcoholism suggests that the treatment drug acamprosate can mitigate those problems and increase the chances for staying sober. ... -Monsters and Critics.com

Alcoholism-treatment drug helps with sleep  Aug 28, 2006
28 (UPI) -- The alcoholism-treatment drug acamprosate, widely used in Europe, may alleviate post-withdrawal sleep disturbances, say French researchers. ... -United Press International

Options abound for people seeking treatment  Sep 6, 2006
While new drugs keep popping up on the market - naltrexone and acamprosate for alcohol dependence and clonidine and buprenorphine for opiate dependence ... -Daily Press

Alcoholism Assessment and Treatment  Sep 2, 2006
During counseling, patients may be able to take an approved medication - naltrexone or acamprosate - or, if a trial is available, an experimental medication to ... -Community Dispatch

Forest Laboratories Inc. Announces Appointment of Dr. Lawrence S. ...  Sep 7, 2006
...receptor blocker and diuretic combination product, each indicated for the treatment of hypertension; and Campral(R)* (acamprosate calcium), indicated in ... -PR Newswire

Acamprosate for Alcohol Dependence: An Update for the Clinician  -  Dec 6, 2006
Focus (subscription)Acamprosate is one of the medications that have shown success in promoting abstinence in alcohol-dependent individuals. For some patients, integrating

Acamprosate May Help Recovering Alcoholics Sleep  -  Nov 28, 2006
About - News & Issues,A French study has found that acamprosate, a medication widely used in Europe to reduce cravings in abstinent alcoholics, may also help them sleep.

Bibliography PSYCHOPHARMACOLOGY  -  Dec 6, 2006
Focus (subscription)Mason BJ, Goodman AM, Chabac S, Lehert P: Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled

Somaxon Pharmaceuticals to Present at the RBC Capital Markets ...  -  Dec 7, 2006
PharmaLive.com (press release),Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. For more information, please visit the company's web

Somaxon Pharmaceuticals to Present at the RBC Capital Markets ...  -  Dec 7, 2006
Genetic Engineering News (press release),...regarding the future of the nalmefene program. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development.

Somaxon Pharmaceuticals to Present at the Piper Jaffray Health ...  -  Nov 21, 2006
Drug Newswire (press release),...a pilot Phase 2 trial for smoking cessation. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development.

Addiction treatment catching up with groundbreaking brain and ...  -  Dec 9, 2006
North County Times,Armed with the science, pharmaceutical companies have responded with three different drugs to combat the cerebral cravings: buprenorphine, acamprosate and

Patient Management Exercise FOR PSYCHOPHARMACOLOGY  -  Dec 6, 2006
Focus (subscription)...+2 D Acamprosate decreases excitatory glutamergic neurotransmission during alcohol withdrawal and thus was approved for relapse prevention.

Lexapro(R) Demonstrated Significance On Prospectively Defined ...  -  Dec 7, 2006
Medical News Today (press release),...an angiotenisn receptor blocker and diuretic combination product, each indicated for the treatment of hypertension; and Campral(R) (acamprosate calcium)

Lexapro(R) Demonstrated Significance on Prospectively Defined ...  -  Dec 6, 2006
Drug Newswire (press release),...and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients

Somaxon Pharmaceuticals to Present at the Piper Jaffray Health ...  -  Nov 21, 2006
Earthtimes.orgAcamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. Contacts: Meg McGilley Chief Financial Officer (858)

Somaxon Pharmaceuticals Names Brian Dorsey Vice President of ...  -  Nov 13, 2006
Earthtimes.orgAcamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. Somaxon cautions you that statements included in this

Health Roundup: Obesity worsens ovarian cancer  29 Aug 2006
Now another study in the new Alcoholism suggests that the treatment drug acamprosate can mitigate those problems and increase the chances for staying sober. ... -Monsters and Critics.com

New drugs, new approach fuel major efforts for many to have ...  Aug 21, 2006
...with the science, pharmaceutical companies have responded with three different drugs to combat the cerebral cravings: buprenorphine, acamprosate and naltrexone ... -Wisconsin State Journal

Somaxon Pharmaceuticals Reports 2006 Second Quarter Financial ...  Aug 9, 2006
TM) (doxepin hydrochloride), Phase 2/3 clinical trial of oral nalmefene for pathological gambling, and formulation development work on acamprosate for movement ... -Yahoo! News

Somaxon Pharmaceuticals Reports 2006 Second Quarter Financial ...  Aug 9, 2006
...doxepin hydrochloride), Phase 2/3 clinical trial of oral nalmefene for pathological gambling, and formulation development work on acamprosate for movement ... -WebWire

Choices abound to help you stay on path to recovery  Aug 7, 2006
While new drugs keep popping up on the market naltrexone and acamprosate for alcohol dependence and clonidine and buprenorphine for opiate dependence ... -Peoria Journal Star

Somaxon Pharmaceuticals Reports Positive Results From a Pilot ...  Jul 26, 2006
...smoking cessation. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. For more ... -Yahoo! News

Somaxon Pharmaceuticals Reports Positive Results From a Pilot ...  Jul 26, 2006
...trial for smoking cessation. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. -PipelineReview.com

Addiction Is a Disease  Jul 19, 2006
...in development including more opiate antagonists for the treatment of alcoholism and opiate dependence and NMDA antagonists such as acamprosate [Campral] for ... -Psychiatric Times

Somaxon Pharmaceuticals to Report 2006 Second Quarter Financial ...  Jul 18, 2006
...smoking cessation. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. For more ... -Drug Newswire

Forest Laboratories, Inc. Reports Fiscal First Quarter 2007 ...  Jul 18, 2006
...receptor blocker and diuretic combination product, each indicated for the treatment of hypertension; and Campral(R)* (acamprosate calcium), indicated in ... -MSN Money

A Cheaper Way to Quit  Jul 13, 2006
The study tested two drugs: naltrexone, which blocks alcohol’s effects on internal opiates in the brain, and acamprosate, which works on the neurotransmitter ... -Brown Alumni Magazine

Forest Announces Federal Court Upholds Lexapro(R) Patent  Jul 13, 2006
...receptor blocker and diuretic combination product, each indicated for the treatment of hypertension; and Campral®* (acamprosate calcium), indicated in ... -Yahoo! News

H. Lundbeck A/S and Forest Laboratories, Inc. file lawsuit against ...  Jul 11, 2006
...an angiotensin receptor blocker and diuretic combination product indicated for the second-line treatment of hypertension; Campral® (acamprosate calcium), a ... -WebWire

A prescription for sobriety  Jul 3, 2006
..."I'd get real depressed when I drank," she said. Anti-craving drugs -- acamprosate or naltrexone -- are another approach to treating alcoholics. ... -Centre Daily Times

For some, breaking alcohol dependency comes with use of strong ...  Jun 27, 2006
Anti-craving drugs — acamprosate or naltrexone — are another approach to treating alcoholics. Sanelli says she rarely prescribes them. ... -Wilkes Barre Times-Leader



Forest and Almirall Announce a Development and Marketing ...  10 Apr 2006
...receptor blocker and diuretic combination product, each indicated for the treatment of hypertension; and Campral(R)* (acamprosate calcium), indicated in ... - Finanzen.net

Somaxon Pharmaceuticals Announces Positive Phase 3 Results with ...  10 Apr 2006
...smoking cessation. Acamprosate Ca, a potential treatment for movement disorders, is currently in formulation development. For more ... - Yahoo! News

Somaxon Pharmaceuticals Reports 2005 Full-Year Financial Results  Mar 21, 2006
Additionally, the company is actively engaged in a reformulation effort with its third compound, acamprosate, which, if successful, Somaxon intends to develop ... - MSN Money

Smoking Causes the Highest Mortality Rate in the US, Accounting ...  Mar 27, 2006
The 2004 approval and 2005 market introduction of acamprosate calcium (Forest Laboratories Campral) for treatment of alcohol dependence and the 2002 ... - Genetic Engineering News

TO YOUR GOOD HEALTH  Mar 13, 2006
...to alcohol. -- TD. ANSWER: I'm happy to publish your story and the success that Campral (acamprosate) has helped bring you. As you ... - Charlotte Sun-Herald

Lactose intolerance can be counteracted with enzymes  Feb 19, 2006
...addiction to alcohol. I'm happy to publish your story and the success that Campral (acamprosate) has helped bring you. As you point ... - SouthCoastToday.com,

What works in alcohol use disorders?  Feb 9, 2006
More recent evidence provides some support for the use of drugs such as acamprosate to prevent relapse in the medium to long term. - Adv Psychiatric Treat (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional